COVID-19 Response at Fishpond

Read what we're doing...

Clinical Exercise Physiology
By

Rating

Product Description
Product Details

Table of Contents

Part I. Introduction to Clinical Exercise PhysiologyChapter 1. The Profession of Clinical Exercise Physiology Jonathan K. Ehrman, PhD, Paul M. Gordon, PhD, MPH, Paul S. Visich, PhD, MPH, and Steven J. Keteyian, PhD The Past, Present, and Future of Clinical Exercise Physiology Professional Organizations and Certifications Throughout the World Professionalization of Clinical Exercise Physiology Conclusion Chapter 2. Promoting a Physically Active Lifestyle Gregory W. Heath, DHSc, MPH, and Josh M. Johann, MS Benefits of Physical Activity Participation in Regular Physical Activity Conclusion Chapter 3. General Principles of Pharmacology Steven J. Keteyian, PhD General Properties of Drugs Routes of Administration Phases of Drug Effect Mechanism of Action Pharmacotherapy Conclusion Chapter 4. General Interview and Examination Skills Quinn R. Pack, MD, MSc, FACC, and Hayden Riley, MS General Interview Physical Examination Conclusion Chapter 5. Graded Exercise Testing Steven J. Keteyian, PhD, and Micah Zuhl, PhD Indications Contraindications Procedures for Preparing, Conducting, and Interpreting a Graded Exercise Test Graded Exercise Testing With Diagnostic Imaging Conclusion Chapter 6. Exercise Prescription Steven J. Keteyian, PhD Exercise Training Sequence Goal Setting Principles of Exercise Prescription Cardiorespiratory Endurance Skeletal Muscle Strength and Endurance Flexibility Training Conclusion Part II. Endocrinology and Metabolic DisordersChapter 7. Diabetes Sheri R. Colberg, PhD, FACSM Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 8. Obesity David C. Murdy, MD, and Jonathan K. Ehrman, PhD, FACSM, FAACVPR, ACSM-CEP Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 9. Hypertension Amanda L. Zaleski, MS, Antonio B. Fernandez, MD, Beth A. Taylor, PhD, and Linda S. Pescatello, PhD, FACSM, FAHA Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 10. Hyperlipidemia and Dyslipidemia Peter W. Grandjean, PhD, FACSM, ACSM-CEP, EIM3, Stephen F. Crouse, PhD, FACSM, J. Larry Durstine, PhD, FACSM, FAACVPR, Paul G. Davis, PhD, FACSM, RCEP, and Benjamin Gordon, PhD, RCEP Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 11. Metabolic Syndrome Mark D. Peterson, PhD, MS, Paul M. Gordon, PhD, MPH, and Flor Elisa Morales, MS Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 12. Chronic Kidney Disease Samuel Headley, PhD, Sahil Bawa, MBBS, and Michael Germain, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part III. Cardiovascular DiseasesChapter 13. Acute Coronary Syndromes: Unstable Angina Pectoris and Acute Myocardial Infarction Ray W. Squires, PhD, MAACVPR, FACSM, FAHA Pathophysiology Clinical Assessment Exercise Training: Inpatient Cardiac Rehabilitation Exercise Training: Early Outpatient Cardiac Rehabilitation Exercise Prescription Conclusion Chapter 14. Revascularization of the Heart Neil A. Smart, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 15. Chronic Heart Failure Steven J. Keteyian, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 16. Peripheral Artery Disease Ryan J. Mays, PhD, MPH, MS, Ivan P. Casserly, MB, BCh, and Judith G. Regensteiner, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 17. Cardiac Electrical Pathophysiology Kerry J. Stewart, EdD, and David D. Spragg, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Part IV. Diseases of the Respiratory SystemChapter 18. Chronic Obstructive Pulmonary Disease Satvir S. Dhillon, MSc, Dennis Jensen, PhD, and Jordan A. Guenette, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 19. Asthma Brian W. Carlin, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 20. Cystic Fibrosis Michael J. Danduran, MS, and Lauren Camarda, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part V. The Immune SystemChapter 21. Cancer Dennis J. Kerrigan, PhD, John R. Schairer, DO, and Kerry S. Courneya, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 22. Human Immunodeficiency Virus Mansueto Neto, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part VI. Disorders of the Bones and the JointsChapter 23. Arthritis Andrew B. Lemmey, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 24. Osteoporosis Lora M. Giangregorio, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 25. Nonspecific Low Back Pain Jan Perkins, PT, PhD, and J. Tim Zipple, PT, DSc Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Part VII. Neuromuscular DisordersChapter 26. Spinal Cord Injury Mary P. Galea, PhD, L. Eduardo Cofre Lizama, PhD, and Andisheh Bastani, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 27. Multiple Sclerosis Linda H. Chung, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 28. Cerebral Palsy Desiree B. Maltais, PT, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 29. Stroke Christopher J. Womack, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 30. Parkinson's Disease Angela L. Ridgel, PhD, and Brandon S. Pollock, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part VIII. Special PopulationsChapter 31. Children Timothy J. Michael, PhD, and William A. Saltarelli, PhD Definition Scope Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 32. Aging Jerome L. Fleg, MD, and Daniel E. Forman, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 33. Depression Benson M. Hoffman, PhD, Krista A. Barbour, PhD, and James A. Blumenthal, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 34. Intellectual Disability Bo Fernhall, PhD, and Tracy Baynard, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion

About the Author

Jonathan K. Ehrman, PhD, FACSM, is the associate program director of preventive cardiology and director of the weight management program at Henry Ford Hospital in Detroit. He has a 33-year background in clinical exercise physiology and is certified by ACSM as aclinical exercise physiologist and as a program director. He previously served as the chair of the clinical exercise physiologist credentialing committee for ACSM. Dr. Ehrman is author of more than 200 manuscripts and abstracts as well as several text books and chapters. He is an associate editor of the most recent edition (10th) of ACSM's Guidelines for Exercise Testing and Prescription. He was also the senior editor of the sixth edition of ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription. He is a fellow of the American College of Sports Medicine and the American Association of Cardiovascular and Pulmonary Rehabilitation and a member the American Heart Association and the American College of Cardiology. Dr. Ehrman earned his PhD in clinical exercise physiology from The Ohio State University. Paul M. Gordon, PhD, MPH, FACSM, is a professor and chair of the department of health, human performance, and recreation at Baylor University. He is certified by the ACSM as a clinical exercise physiologist and has over 20 years of experience teaching clinical exercise physiology curricula and directing cardiopulmonary rehabilitation programs. Dr. Gordon has published more than 200 papers and abstracts and several chapters, including in ACSM's Guidelines for Exercise Testing and Prescription. He has also served as an examiner and coordinator for ACSM certification and credentialing. Dr. Gordon is a fellow of the American College of Sports Medicine, the Obesity Society, and the Centers for Disease Control Physical Activity Research Program. He is an international member of the Royal Society for Medicine. He earned his PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh. Paul S. Visich, PhD, MPH, has nearly 20 years of experience in clinical exercise physiology and is the director of the Human Performance Laboratory in the College of Health Professions at Central Michigan University. He worked for 12 years in a clinical setting that included cardiac and pulmonary rehabilitation and primary disease prevention. His research interests involve the assessment of cardiovascular disease risk factors in children, the influence of resistance training in elderly populations, and altitude physiology. Dr. Visich is a member of ACSM's exercise physiology credentialing committee and previous chair of their professional education committee. He is the author of more than 70 published scientific articles and abstracts. He earned a PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh. Steven J. Keteyian, PhD, FACSM, has more than 35 years of experience working as a clinical exercise physiologist. He is program director of preventive cardiology at the Henry Ford Hospital in Detroit. Over the course of his career, Dr. Keteyian has focused on exercise and physical activity in both healthy individuals and those with chronic diseases. He is the author of more than 100 scientific articles and book chapters as well as four textbooks. Dr. Keteyian is a member of the American Associatioon of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. He is a fellow of the American College of Sports Medicine. He earned his PhD from Wayne State University in Detroit.

Ask a Question About this Product More...
Write your question below:
Look for similar items by category
Item ships from and is sold by Fishpond Retail Limited.
Back to top